The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a recent review article.

The Missouri Botanical Garden announced the launch of its new Revolutionizing Species Identification Program, or the RSI project, which is a transformative initiative to digitize the Missouri ...

On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK, ...

"To be one of the first academic medical centers in the United States to do this is remarkable," Dr. Mike Laposata, chair of UTMB Galveston's pathology department said.

The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the ...

A HER2-positive status reflects breast cancer cells with extra copies of the HER2 gene, or higher expression of HER2 proteins ...

Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of ...

Since 2021, the number of people getting diagnosed with ADHD for the first time has risen significantly. In other news: Americans live with diseases longer than people from other countries; some foods ...

Project EVOLVE, funded by Daiichi Sankyo and AstraZeneca, to be presented at the 2024 San Antonio Breast Cancer Symposium -- NEW YORK, Dec. 12, 2024 /PRNewswire/ -- Novellia, Inc., an AI-enabled ...

A new AI-powered blood test is the first to detect signs of breast cancer in its earliest stages when it is “far more easily treated”, scientists have announced. The new non-invasive test works by ...

Patients included in the trial had HR+/HER2– metastatic breast cancer, were 18 years or older, and started index treatment ...